CN Stock MarketDetailed Quotes

688117 Cheng Du Sheng Nuo Biotec

Watchlist
  • 23.33
  • +0.90+4.01%
Post Market Jul 12 15:00 CST
2.61BMarket Cap35.89P/E (TTM)

Cheng Du Sheng Nuo Biotec Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Total operating revenue
27.65%104.06M
9.93%435.02M
11.82%291.23M
3.78%173.83M
0.96%81.52M
2.38%395.72M
-6.70%260.43M
-13.49%167.51M
-13.44%80.74M
2.05%386.53M
Operating revenue
27.65%104.06M
9.93%435.02M
11.82%291.23M
3.78%173.83M
0.96%81.52M
2.38%395.72M
-6.70%260.43M
-13.49%167.51M
-13.44%80.74M
2.05%386.53M
Total operating cost
19.14%86.93M
11.01%357.48M
17.38%254.71M
5.89%157.57M
10.64%72.96M
1.61%322.02M
-5.88%216.99M
-10.23%148.81M
-17.56%65.95M
1.46%316.92M
Operating cost
32.20%38.37M
15.37%157.65M
14.95%107.76M
2.29%61.07M
10.01%29.03M
26.13%136.64M
33.17%93.75M
26.27%59.71M
37.17%26.38M
37.55%108.33M
Operating tax surcharges
122.81%1.32M
-14.54%4.03M
-22.69%2.61M
-26.67%1.83M
-53.10%594.35K
-1.71%4.72M
1.68%3.37M
7.56%2.49M
17.77%1.27M
13.09%4.8M
Operating expense
19.93%23.18M
-4.65%107.97M
6.91%79.66M
-4.27%48.77M
-20.92%19.33M
-25.37%113.24M
-39.40%74.52M
-43.38%50.95M
-47.57%24.44M
-16.56%151.73M
Administration expense
-25.85%12.62M
17.92%53.86M
39.73%40.78M
45.14%30.71M
86.15%17.02M
13.75%45.68M
7.65%29.19M
10.10%21.16M
5.50%9.14M
31.43%40.16M
Financial expense
-5.30%2.02M
417.50%4.91M
232.06%3.52M
232.99%2.01M
639.17%2.14M
16.31%-1.55M
-23.85%-2.66M
-434.76%-1.51M
34.44%-396.26K
-42.89%-1.85M
-Interest expense (Financial expense)
47.75%2.94M
164.68%9.26M
199.24%6.83M
303.35%4.34M
339.82%1.99M
1,949.84%3.5M
8,811.52%2.28M
--1.08M
--451.87K
813.18%170.76K
-Interest Income (Financial expense)
-14.86%-838.48K
-86.50%-3.92M
-96.23%-2.73M
-78.71%-2.01M
-20.48%-729.97K
23.19%-2.1M
46.39%-1.39M
-70.84%-1.13M
-57.50%-605.88K
-79.24%-2.74M
Research and development
93.65%9.42M
24.74%29.05M
8.23%20.38M
-17.69%13.18M
-4.87%4.86M
69.40%23.29M
111.11%18.83M
120.57%16.01M
2.00%5.11M
-24.67%13.75M
Credit Impairment Loss
408.03%1.43M
12.71%-3.05M
-3.57%-593.15K
-200.53%-656.3K
-208.26%-464.7K
-171.12%-3.49M
-275.10%-572.68K
13.44%-218.38K
-31.21%429.23K
-22.89%-1.29M
Asset Impairment Loss
-289.31%-874.48K
-2.68%-4.93M
-361.49%-4.26M
-4,699.08%-2.51M
-3,393.77%-224.62K
-280.75%-4.8M
-221.60%-924.17K
90.59%-52.39K
98.33%-6.43K
79.92%-1.26M
Other net revenue
Invest income
153.81%298.89K
-157.63%-1.42M
-163.84%-900.47K
-146.82%-404.08K
-150.70%-555.46K
68.33%2.47M
--1.41M
--863.08K
--1.1M
--1.46M
-Including: Investment income associates
----
-66.18%-3.17M
----
----
----
---1.91M
----
----
----
----
Asset deal income
103.30%35
98.66%-1.06K
90.48%-1.06K
90.48%-1.06K
90.48%-1.06K
-487.73%-79.37K
---11.15K
---11.15K
---11.15K
---13.5K
Other revenue
-82.22%1.61M
156.62%12.96M
255.64%11.18M
334.04%10.74M
579.05%9.04M
-30.84%5.05M
-31.97%3.14M
-32.59%2.47M
111.26%1.33M
-31.71%7.3M
Operating profit
19.82%19.59M
11.34%81.1M
-9.79%41.94M
7.69%23.43M
-7.31%16.35M
-3.92%72.84M
-12.68%46.49M
-29.20%21.76M
24.60%17.64M
8.63%75.81M
Add:Non operating Income
265,909.48%21.33K
9,770.38%333.48K
3,473.84%318.49K
2,926.72%247.89K
-99.90%8.02
-83.59%3.38K
-92.56%8.91K
-93.14%8.19K
-88.51%7.95K
-74.81%20.59K
Less:Non operating expense
1,780.04%307.63K
173.22%1.31M
207.97%1.19M
151.89%893.34K
-80.75%16.36K
-91.01%480.58K
-86.35%386.33K
-85.13%354.66K
-90.60%85K
440.32%5.34M
Total profit
18.19%19.3M
10.72%80.12M
-10.94%41.06M
6.42%22.78M
-7.00%16.33M
2.66%72.36M
-8.74%46.11M
-24.78%21.41M
31.84%17.56M
2.33%70.49M
Less:Income tax cost
24.08%2.85M
24.34%9.8M
-11.77%6.27M
-4.79%2.64M
-29.65%2.3M
-14.68%7.88M
-5.18%7.1M
-37.84%2.77M
96.18%3.27M
3.97%9.24M
Net profit
17.23%16.45M
9.06%70.32M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
22.64%14.29M
2.09%61.25M
Net profit from continuing operation
17.23%16.45M
9.06%70.32M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
22.64%14.29M
2.09%61.25M
Less:Minority Profit
---22.09K
---12.7K
----
----
----
----
----
----
----
----
Net profit of parent company owners
17.38%16.47M
9.08%70.34M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
22.64%14.29M
2.09%61.25M
Earning per share
Basic earning per share
15.38%0.15
8.62%0.63
-11.43%0.31
5.88%0.18
-27.78%0.13
-31.76%0.58
-43.55%0.35
-55.26%0.17
-5.26%0.18
-15.00%0.85
Diluted earning per share
15.38%0.15
6.90%0.62
-11.43%0.31
5.88%0.18
-27.78%0.13
-31.76%0.58
-43.55%0.35
-55.26%0.17
-5.26%0.18
-15.00%0.85
Other composite income
Total composite income
17.23%16.45M
9.06%70.32M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
22.64%14.29M
2.09%61.25M
Total composite income of parent company owners
17.38%16.47M
9.08%70.34M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
22.64%14.29M
2.09%61.25M
Total composite income of minority owners
---22.09K
---12.7K
----
----
----
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
--
Auditor
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Total operating revenue 27.65%104.06M9.93%435.02M11.82%291.23M3.78%173.83M0.96%81.52M2.38%395.72M-6.70%260.43M-13.49%167.51M-13.44%80.74M2.05%386.53M
Operating revenue 27.65%104.06M9.93%435.02M11.82%291.23M3.78%173.83M0.96%81.52M2.38%395.72M-6.70%260.43M-13.49%167.51M-13.44%80.74M2.05%386.53M
Total operating cost 19.14%86.93M11.01%357.48M17.38%254.71M5.89%157.57M10.64%72.96M1.61%322.02M-5.88%216.99M-10.23%148.81M-17.56%65.95M1.46%316.92M
Operating cost 32.20%38.37M15.37%157.65M14.95%107.76M2.29%61.07M10.01%29.03M26.13%136.64M33.17%93.75M26.27%59.71M37.17%26.38M37.55%108.33M
Operating tax surcharges 122.81%1.32M-14.54%4.03M-22.69%2.61M-26.67%1.83M-53.10%594.35K-1.71%4.72M1.68%3.37M7.56%2.49M17.77%1.27M13.09%4.8M
Operating expense 19.93%23.18M-4.65%107.97M6.91%79.66M-4.27%48.77M-20.92%19.33M-25.37%113.24M-39.40%74.52M-43.38%50.95M-47.57%24.44M-16.56%151.73M
Administration expense -25.85%12.62M17.92%53.86M39.73%40.78M45.14%30.71M86.15%17.02M13.75%45.68M7.65%29.19M10.10%21.16M5.50%9.14M31.43%40.16M
Financial expense -5.30%2.02M417.50%4.91M232.06%3.52M232.99%2.01M639.17%2.14M16.31%-1.55M-23.85%-2.66M-434.76%-1.51M34.44%-396.26K-42.89%-1.85M
-Interest expense (Financial expense) 47.75%2.94M164.68%9.26M199.24%6.83M303.35%4.34M339.82%1.99M1,949.84%3.5M8,811.52%2.28M--1.08M--451.87K813.18%170.76K
-Interest Income (Financial expense) -14.86%-838.48K-86.50%-3.92M-96.23%-2.73M-78.71%-2.01M-20.48%-729.97K23.19%-2.1M46.39%-1.39M-70.84%-1.13M-57.50%-605.88K-79.24%-2.74M
Research and development 93.65%9.42M24.74%29.05M8.23%20.38M-17.69%13.18M-4.87%4.86M69.40%23.29M111.11%18.83M120.57%16.01M2.00%5.11M-24.67%13.75M
Credit Impairment Loss 408.03%1.43M12.71%-3.05M-3.57%-593.15K-200.53%-656.3K-208.26%-464.7K-171.12%-3.49M-275.10%-572.68K13.44%-218.38K-31.21%429.23K-22.89%-1.29M
Asset Impairment Loss -289.31%-874.48K-2.68%-4.93M-361.49%-4.26M-4,699.08%-2.51M-3,393.77%-224.62K-280.75%-4.8M-221.60%-924.17K90.59%-52.39K98.33%-6.43K79.92%-1.26M
Other net revenue
Invest income 153.81%298.89K-157.63%-1.42M-163.84%-900.47K-146.82%-404.08K-150.70%-555.46K68.33%2.47M--1.41M--863.08K--1.1M--1.46M
-Including: Investment income associates -----66.18%-3.17M---------------1.91M----------------
Asset deal income 103.30%3598.66%-1.06K90.48%-1.06K90.48%-1.06K90.48%-1.06K-487.73%-79.37K---11.15K---11.15K---11.15K---13.5K
Other revenue -82.22%1.61M156.62%12.96M255.64%11.18M334.04%10.74M579.05%9.04M-30.84%5.05M-31.97%3.14M-32.59%2.47M111.26%1.33M-31.71%7.3M
Operating profit 19.82%19.59M11.34%81.1M-9.79%41.94M7.69%23.43M-7.31%16.35M-3.92%72.84M-12.68%46.49M-29.20%21.76M24.60%17.64M8.63%75.81M
Add:Non operating Income 265,909.48%21.33K9,770.38%333.48K3,473.84%318.49K2,926.72%247.89K-99.90%8.02-83.59%3.38K-92.56%8.91K-93.14%8.19K-88.51%7.95K-74.81%20.59K
Less:Non operating expense 1,780.04%307.63K173.22%1.31M207.97%1.19M151.89%893.34K-80.75%16.36K-91.01%480.58K-86.35%386.33K-85.13%354.66K-90.60%85K440.32%5.34M
Total profit 18.19%19.3M10.72%80.12M-10.94%41.06M6.42%22.78M-7.00%16.33M2.66%72.36M-8.74%46.11M-24.78%21.41M31.84%17.56M2.33%70.49M
Less:Income tax cost 24.08%2.85M24.34%9.8M-11.77%6.27M-4.79%2.64M-29.65%2.3M-14.68%7.88M-5.18%7.1M-37.84%2.77M96.18%3.27M3.97%9.24M
Net profit 17.23%16.45M9.06%70.32M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M22.64%14.29M2.09%61.25M
Net profit from continuing operation 17.23%16.45M9.06%70.32M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M22.64%14.29M2.09%61.25M
Less:Minority Profit ---22.09K---12.7K--------------------------------
Net profit of parent company owners 17.38%16.47M9.08%70.34M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M22.64%14.29M2.09%61.25M
Earning per share
Basic earning per share 15.38%0.158.62%0.63-11.43%0.315.88%0.18-27.78%0.13-31.76%0.58-43.55%0.35-55.26%0.17-5.26%0.18-15.00%0.85
Diluted earning per share 15.38%0.156.90%0.62-11.43%0.315.88%0.18-27.78%0.13-31.76%0.58-43.55%0.35-55.26%0.17-5.26%0.18-15.00%0.85
Other composite income
Total composite income 17.23%16.45M9.06%70.32M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M22.64%14.29M2.09%61.25M
Total composite income of parent company owners 17.38%16.47M9.08%70.34M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M22.64%14.29M2.09%61.25M
Total composite income of minority owners ---22.09K---12.7K--------------------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion--------
Auditor --Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
%Chg